Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Austin, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Next Generation Biometrics Market Size & Growth Insights: According to the SNS Insider,“The Next Generation Biometrics Market size was valued at USD...
-
Ecosystem Expansion and Global Strategy Drive Unprecedented Performance SINGAPORE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- JuCoin's platform token JU has broken through the $20 barrier, marking a...
-
ATLANTA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (the “Company” or “Femasys”), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide,...
-
Chicago, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The global viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is expected to reach US$ 20.30 billion by 2033,...
-
Dublin, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The "Wastewater Treatment Services - Company Evaluation Report, 2025" report has been added to ResearchAndMarkets.com's offering.The Wastewater Treatment...
-
Memorial Health Group launches Rememore in Istanbul, redefining luxury medical tourism by blending world-class healthcare with bespoke travel experiences.
-
-- First in the FemSperm family, the Setup Kit enables gynecologists to offer FemaSeed directly, expanding access ahead of IVF and driving revenue growth -- ATLANTA, Aug. 21, 2025 (GLOBE...
-
HO CHI MINH CITY, Vietnam, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The 19th Ho Chi Minh City International Travel Expo – ITE HCMC 2025 will officially take place from September 4th – 6th, 2025 at the...
-
Company Announcement no. 08/2025 cBrain® advances global growth strategy, maintaining long-term focus Copenhagen, August 21, 2025 We are now entering the final half year of our 2023–2025...
-
--Advances European commercialization strategy following CE mark approval-- ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making...